Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2014-02-11Clinical Trial Update: AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDS [Phase 1, Phase 2]
A Phase 1/2 trial evaluating AMD3100 with busulfan, fludarabine, and thymoglobulin for allogeneic stem cell transplantation in acute myeloid…
-
CLINICAL_TRIALS withdrawal · 2014-01-03Clinical Trial Update: ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia [Phase 1]
The clinical trial evaluating ALT-801-activated natural killer cells with FLAG induction for acute myeloid leukemia (NCT01478074) has been w…
-
CLINICAL_TRIALS withdrawal · 2013-11-06Clinical Trial Update: A Phase 2 Study of Tandutinib in Patients With Newly Diagnosed Acute Myelogenous Leukemia Who Are Considered Ineligible For or Who Decline Treatment With Standard Induction Therapy [Phase 1, Phase 2]
A Phase 1/2 study of tandutinib in newly diagnosed acute myeloid leukemia patients who are ineligible for or decline standard induction ther…
-
CLINICAL_TRIALS withdrawal · 2013-06-12Clinical Trial Update: Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting [NA]
A pediatric clinical trial evaluating acupuncture point stimulation to prevent chemotherapy-induced nausea and vomiting has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-04-02Clinical Trial Update: A Multi-Center Phase 2 Study of VEGF Trap as a Single Agent in Acute Myeloid Leukemia [Phase 2]
A multi-center Phase 2 study of VEGF Trap as a single agent in acute myeloid leukemia has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2012-12-18Clinical Trial Update: Phase 3 Trial for AML Patients in CR2 Comparing 8Gy TBI /Fludarabine to Conditioning With TBI 12Gy/Cyclophosphamide [Phase 3]
Phase 3 AML trial comparing 8 Gy total body irradiation with fludarabine versus 12 Gy TBI with cyclophosphamide was terminated.
-
CLINICAL_TRIALS withdrawal · 2012-07-09Clinical Trial Update: Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant [NA]
A clinical trial evaluating mechanical stimulation to prevent bone density loss in patients undergoing donor stem cell transplant has been w…
-
CLINICAL_TRIALS withdrawal · 2011-04-08Clinical Trial Update: To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning [Phase 3]
A Phase 3 clinical trial evaluating adding Campath-1H (alemtuzumab) or ATG to fludarabine and low-dose busulfan conditioning for acute myelo…
-
CLINICAL_TRIALS withdrawal · 2008-10-31Clinical Trial Update: A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating CLAG with imatinib (Gleevec) for refractory/relapsed chronic myeloid leukemia and acute myeloid leukemia has been w…
-
EMA withdrawal · 2008-01-24EMA Refused: Mylotarg (gemtuzumab ozogamicin) — Wyeth Europa Ltd
The EMA refused approval for Mylotarg (gemtuzumab ozogamicin) by Wyeth Europa Ltd for acute myeloid leukemia.
-
CLINICAL_TRIALS withdrawal · 2006-11-03Clinical Trial Update: Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) [Phase 2]
A Phase 2 clinical trial for relapsed or refractory acute myeloid leukemia sponsored by SGX Pharmaceuticals has been terminated.